$RGEN
Repligen Corp
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$173.88
▲+6.13%+$10.04
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRepligen Corp
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RGEN up today? It is at $173.88 (+6.13%), and our scanner flagged it 97 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RGEN spikes, and full due diligence on RGEN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RGEN 97 times in the last 30 days. Create a free account to track $RGEN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Oct 9, 2026 · 2 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Douglass Brian Robb Officer | Acquired (grant/award) | +700 | added 8.8% | 9K | n/a | Oct 6, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -6K | sold 11% | 46K | $989K at $178.75 | Oct 5, 26 |
Loeillot Olivier Officer | Other | 4K | added 9.2% | 50K | $651K at $154.96 | Oct 5, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -1K | sold 2.6% | 47K | $227K at $181.70 | Oct 2, 26 |
Garland Jason K Officer | Sold (automatic/other) | -421 | sold 2.2% | 18K | $80K at $189.68 | Sep 25, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -13K 0.02% of company | sold 21% | 48K | $2.5M at $190.00 | Sep 24, 26 |
Loeillot Olivier Officer | Other | 13K 0.02% of company | added 30% | 57K | $2.0M at $154.96 | Sep 24, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -5K | sold 10% | 48K | $977K at $180.00 | Sep 21, 26 |
Loeillot Olivier Officer | Other | 5K | added 11% | 54K | $769K at $141.79 | Sep 21, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -3K | sold 5.9% | 48K | $504K at $165.90 | Sep 4, 26 |
Loeillot Olivier Officer | Sold (automatic/other) | -3K | sold 5.2% | 51K | $482K at $169.61 | Sep 3, 26 |
Hughes Violetta Officer | Sold (automatic/other) | -277 | sold 4.2% | 6K | $47K at $170.02 | Sep 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on RGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RGEN last traded at $173.88, up 6.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Repligen Corp (RGEN) is next expected to report earnings on Tuesday, October 27, 2026, about 17 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RGEN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RGEN 97 times in the last 30 days.
RGEN (Repligen Corp) trades on XNAS, with a market cap of about $11.04B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RGEN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RGEN discussion
Sign in to ask a question or join the discussion.